Stockscreener 앱 받기
4.78
3.63%
-0.18
Avita Medical Inc 주식(RCEL)의 최신 뉴스
Avita Medical (NASDAQ:RCEL) Now Covered by Analysts at Northland Securities - MarketBeat
Avita Medical at TD Cowen Conference: Growth and Strategic Focus By Investing.com - Investing.com Canada
RCEL SEC FilingsAvita Medical Inc 10-K, 10-Q, 8-K Forms - Stock Titan
RCELAVITA Medical Reports Fourth Quarter and Full Year 2025 Financial Results - ADVFN Ltd
RCEL Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Retail Trends: Can AVITA Medical Inc weather a recession2025 Trade Ideas & Reliable Momentum Entry Alerts - baoquankhu1.vn
Wall Street Analysts Believe Avita Medical (RCEL) Could Rally 29.87%: Here's is How to Trade - Zacks Investment Research
Avita Medical Inc. (NASDAQ:RCEL) Given Consensus Rating of "Hold" by Analysts - MarketBeat
Avita Medical Targets “Progressive” 2026 Growth, Guides $80M-$85M Revenue After Headwind Year - MarketBeat
Wall Street experts predict Avita Medical (RCEL) may surge by 29.87%: Here’s how you can approach trading - Bitget
AVITA Medical to participate at the TD Cowen 46th Annual Health Care Conference - Investing News Network
Avita Medical (NASDAQ:RCEL) CFO David O'toole Purchases 3,000 Shares of Stock - MarketBeat
AVITA Medical, Inc. (NASDAQ:RCEL) Q4 2025 earnings call transcript - MSN
AVITA Medical (RCEL) CFO awarded RSU and stock option grants - Stock Titan
Avita Medical (RCEL) Upgraded to Buy: Here's What You Should Know - Yahoo Finance
Scar Treatment Market Size is Expected to Reach USD 56.30 Billion by 2033; Growth is Propelling Due to the Surging Awareness for Advanced Cosmetic and Reconstructive Procedures Globally - GlobeNewswire Inc.
RCEL: D. Boral Capital Maintains "Buy" Rating and $10 PT | RCEL Stock News - GuruFocus
Avita Medical (NASDAQ:RCEL) Earns "Buy" Rating from D. Boral Capital - MarketBeat
Broker tips 25% upside for this ASX healthcare stock following FY25 earnings results - MSN
Earnings call transcript: Avita Medical Q4 2025 sees steady revenue growth - Investing.com Nigeria
Avita Medical Earnings Call Signals Stabilizing Growth - The Globe and Mail
Avita's Road to Profitability Is in Sight - Morningstar
AVITA Medical to Host Investor Webinar Briefing - Investing News Network
Ask AVITA Medical’s interim CEO your questions in Feb. 18 investor webinar Q&A - Stock Titan
AVITA Medical, Inc. (NASDAQ:RCEL) Q4 2025 Earnings Call Transcript - Insider Monkey
Avita Medical Q4 2025 slides: 11% annual growth with 12-19% expansion targeted for 2026 - Investing.com Canada
Earnings call transcript: Avita Medical Q4 2025 sees steady revenue growth By Investing.com - Investing.com South Africa
AVITA Medical (RCEL) Reports Strong Q4 2025 Performance - GuruFocus
Avita Medical Q4 Earnings Call Highlights - MarketBeat
AVITA Medical, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
AVITA Medical (RCEL) Q4 2025 Earnings Transcript - The Globe and Mail
RCEL Refines Financial Strategy with New Credit Facility - GuruFocus
Avita Medical (RCEL) Reports Lower Q4 Revenue Amidst Operational Transition - GuruFocus
Avita Medical earnings matched, revenue topped estimates By Investing.com - Investing.com Canada
AVITA Medical to Announce Q4 Earnings on February 12 - Intellectia AI
Avita Medical (NASDAQ:RCEL) Issues Earnings Results, Misses Expectations By $0.02 EPS - MarketBeat
AVITA Medical, Inc. SEC 10-K Report - TradingView
AVITA Medical Q4 Earnings Summary & Key Takeaways - Benzinga
AVITA Medical Reports Fourth Quarter and Full Year 2025 Financial Results - Bluefield Daily Telegraph
Lake Street raises price target on AVITA Medical, Inc. (RCEL) to $3.50, maintains hold rating - MSN
AVITA Medical Inc (AVHHL) Q4 2025 Earnings Call Highlights: Navigating Growth and Challenges By GuruFocus - Investing.com Canada
Is AVITA Medical Inc. forming a bullish divergenceEarnings Recap Summary & Fast Entry and Exit Trade Plans - mfd.ru
Bull Run: Can AVITA Medical Inc weather a recessionMarket Performance Summary & Precise Buy Zone Identification - baoquankhu1.vn
Is AVITA Medical Inc. stock a buy before product launchesTrade Risk Report & Fast Exit and Entry Trade Guides - mfd.ru
Aug Volume: What is the dividend yield of GOOSJuly 2025 EndofMonth & Verified Entry Point Signals - baoquankhu1.vn
Lake Street Raises Price Target on AVITA Medical, Inc. (RCEL) to $3.50, Maintains Hold Rating - Finviz
Avita Medical (RCEL) to Release Quarterly Earnings on Thursday - MarketBeat
2.40%
자본화:
|
볼륨(24시간):